Compare DexCom, Inc. (DXCM) vs FuelCell Energy Inc (FCEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs FuelCell Energy Inc — how do they compare? DexCom, Inc. trades at $90.38 (market cap $33.79B), while FuelCell Energy Inc trades at $22.57 (market cap $1.54B). The key difference: DexCom, Inc. is far larger — about 21.9× FuelCell Energy Inc's market cap, and DexCom, Inc. is trading nearer its 52-week high, FuelCell Energy Inc nearer its low. Which is the better fit depends on your goals.
| DXCM | FCEL | |
|---|---|---|
Market Cap | $33.79B | $1.54B |
Sector | Health | Industrials |
52-Week High | $89.53 | $36.01 |
52-Week Low | $54.84 | $3.92 |
Enterprise Value | $33.24B | $1.38B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $90.23, up 2.94% today and near its 52-week high, with a bullish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating EPS estimates with $0.70 versus $0.61 expected, and raised full-year guidance. Revenue growth remains robust at 13% year-over-year, supported by G7 system adoption and international expansion. Profit margins improved, with net income margin reaching 20.12% in 2025. Analyst sentiment is overwhelmingly positive, with 80% buy ratings.
The outlook for DXCM is favorable due to sustained demand for continuous glucose monitors and strategic initiatives like 'Road to 100'. Key risks include competitive pressures, regulatory scrutiny, and valuation multiples above industry averages. The stock's current price is slightly above the consensus target of $88.65, suggesting near-term consolidation may occur before further upside.
FCEL trades at $21.32, up 7.51% in the last 24 hours, with a bearish technical signal and RSI near oversold levels. The company reported a net loss of $187.9 million in 2025, with negative gross and net income margins, though revenue grew to $158.16 million. Recent news highlights partnerships with Siemens and focus on AI-driven power demand, but cash flow from operations remains negative.
The outlook is mixed: analyst consensus is split between Buy and Hold with a $20.75 price target, slightly below current price. Key risks include persistent losses, high cash burn, and competitive pressures in the hydrogen sector. Upside potential hinges on execution of growth initiatives and profitability improvements.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About FuelCell Energy Inc
FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products, which efficiently convert chemical energy in fuels into electricity through a series of chemical reactions. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company generates a majority of its revenue from the United States followed by South Korea.
Read more on FCEL →
